Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000494:pharmacology; D002102:Cadaver; D002648:Child; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects; D006760:Hospitalization; D006801:Humans; D007165:Immunosuppression Therapy; D007263:Infusions, Parenteral; D007668:Kidney / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000534:rehabilitation* / Q000628:therapy; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000494:pharmacology; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D006435:Renal Dialysis; D014019:Tissue Donors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone